nerve damage

Case Western Reserve University startup, NervGen Pharma, raises $7.5M from initial public offering

March 15, 2019

NervGen Pharma Corp., a Vancouver-based company founded to develop regenerative-medicine technology licensed from Case Western Reserve University, raised...

Featured Health & Wellness Research Science & Tech University News

Case Western Reserve, NervGen sign license agreement to develop therapies for spinal-cord injury and other nerve-damage conditions

July 24, 2018

Case Western Reserve University and NervGen Pharma Corp., based in Vancouver, have entered into an exclusive licensing agreement to research,...

Featured Health & Wellness Science & Tech